Imaging of Uterine Cancer

Radiologic Clinics of North America

Volumn 45, Issue 1, 2007, Pages 167-182

  Akin, Oguz ^a,b   Mironov, Svetlana ^a,b   Pandit Taskar, Neeta ^a,b   Hann, Lucy E ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER DIAGNOSIS; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOMETRIUM CARCINOMA; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

CERVIX UTERI; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; UTERUS;

EID: 33845202480     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2006.10.009     Document Type: Review

References (87)

1. American Cancer Society. Cancer facts and figures: 2006 (2006), American Cancer Society, Atlanta (GA)
2. Soliman P.T., Oh J.C., Schmeler K.M., et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105 3 (2005) 575-580
3. Goldstein R.B., Bree R.L., Benson C.B., et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med 20 (2001) 1025-1036
4. Goldstein S.R., Zeltser I., Horan C.K., et al. Ultrasonographically-based triage for perimenopausal patients with abnormal uterine bleeding. Am J Obstet Gynecol 177 (1997) 102-108
5. Medverd J.R., and Dubinsky T.J. Cost analysis model: US versus endometrial biopsy in evaluation of peri-and postmenopausal abnormal vaginal bleeding. Radiology 222 (2002) 619-627
6. Smith P., Bakos O., Heimer G., et al. Transvaginal ultrasound for identifying endometrial abnormality. Acta Obstet Gynecol Scand 70 (1991) 591-594
7. Karlsson B., Granberg S., Wikland M., et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: a Nordic multicenter study. Am J Obstet Gynecol 172 (1995) 1488-1494
8. Smith-Bindman R., Kerlikowske K., Feldstein V.A., et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280 (1998) 1510-1517
9. Dubinsky T.J., Parvey H.R., and Maklad N. The role of transvaginal sonography and endometrial biopsy in the evaluation of peri-and postmenopausal bleeding. AJR Am J Roentgenol 169 (1997) 145-149
10. Deckardt R., Lueken R.P., Gallinat A., et al. Comparison of transvaginal ultrasound, hysteroscopy and dilatation and curettage in the diagnosis of abnormal vaginal bleeding and intrauterine pathology in perimenopausal and postmenopausal women. J Am Assoc Gynecol Laparosc 9 (2002) 277-282
11. Gerber B., Krause A., Muller H., et al. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. Eur J Cancer 37 (2001) 64-71
12. Langer R.D., Pierce J.J., O'Hanlan K.A., et al. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. N Engl J Med 337 (1997) 1793-1798
13. Barakat R.R. Contemporary issues in the management of endometrial cancer. CA Cancer J Clin 48 (1998) 299-314
14. Dove-Edwin I., Boks D., Goff S., et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 15 (2002) 1708-1712
15. Benedet J.L., Bender H., Jones III H., et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers: FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70 (2000) 209-262
16. th edition (2002), Springer-Verlag, New York
17. Sheikh M., Sawhney S., Khurana A., et al. Alteration of sonographic texture of the endometrium in post-menopausal bleeding: a guide to further management. Acta Obstet Gynecol Scand 79 (2000) 1006-1010
18. Nalaboff K.M., Pellerito J.S., and Ben-Levi E. Imaging the endometrium: disease and normal variants. Radiographics 21 (2001) 1409-1424
19. Bree R.L., Bowerman R.A., Bohm-Velez M., et al. US evaluation of the uterus in patients with postmenopausal bleeding: a positive effect on diagnostic decision making. Radiology 216 (2000) 260-264
20. Dubinsky T.J., Stroehlein K., Abu-Ghazzeh Y., et al. Prediction of benign and malignant endometrial disease: hysterosonographic-pathologic correlation. Radiology 210 (1999) 393-397
21. Alcazar J.L., Errasti T., and Zornoza A. Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet Gynecol Scand 79 (2000) 321-322
22. Sawicki V., Spiewankiewicz B., Stelmachow J., et al. Color Doppler assessment of blood flow in endometrial cancer. Eur J Gynaecol Oncol 26 (2005) 279-284
23. Alcazar J.L., Ajossa S., Floris S., et al. Reproducibility of endometrial vascular patterns in endometrial disease as assessed by transvaginal power Doppler sonography in women with postmenopausal bleeding. J Ultrasound Med 25 (2006) 159-163
24. Timmerman D., Verguts J., and Konstantinovic M.L. The pedicle artery sign based on sonography with color Doppler imaging can replace second stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol 22 (2003) 166-177
25. Bourne T.H., Campbell S., Steer C.V., et al. Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: a preliminary report. Gynecol Oncol 40 (1991) 253-259
26. Teefey S.A., Stahl J.A., Middleton W.D., et al. Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection. AJR Am J Roentgenol 166 (1996) 547-552
27. Arko D., and Takac I. High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. J Ultrasound Med 29 (2000) 639-643
28. Fishman A., Altara M., Bernheim J., et al. The value of transvaginal sonography in the preoperative assessment of myometrial invasion in high and low grade endometrial cancer and in comparison to frozen section in grade I disease. Eur J Gynaecol Oncol 21 (2000) 128-130
29. Kinkel K., Yasushi K., Yu K.K., et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212 (1999) 711-718
30. Balfe D.M., Van Dyke J., Lee J.K., et al. Computed tomography in malignant endometrial neoplasms. J Comput Assist Tomogr 7 (1983) 677-681
31. Walsh J.W., and Goplerud D.R. Computed tomography of primary, persistent, and recurrent endometrial malignancy. AJR Am J Roentgenol 139 (1982) 1149-1154
32. Hardesty L.A., Sumkin J.H., Hakim C., et al. The ability of helical CT to preoperatively stage endometrial carcinoma. AJR Am J Roentgenol 176 (2001) 603-606
33. Creasman W.T., Morrow C.P., Bundy B.N., et al. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 60 (1987) 2035-2041
34. Hirano Y., Kubo K., Hirai Y., et al. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms. Radiographics 12 (1992) 243-256
35. Hricak H., Rubinstein L.V., Gherman G.M., et al. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179 (1991) 829-832
36. Lien H.H., Blomlie V., Trope C., et al. Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. AJR Am J Roentgenol 157 (1991) 1221-1223
37. Manfredi R., Mirk P., Maresca G., et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231 (2004) 372-378
38. Frei K.A., Kinkel K., Bonel H.M., et al. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging: a meta-analysis and Bayesian analysis. Radiology 216 (2000) 444-449
39. Kodama S., Kase H., Tanaka K., et al. Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynaecol Obstet 53 (1996) 23-30
40. Varpula M.J., and Klemi P.J. Staging of uterine endometrial carcinoma with ultra-low field (0.02 T) MRI: a comparative study with CT. J Comput Assist Tomogr 17 (1993) 641-647
41. DelMaschio A., Vanzulli A., Sironi S., et al. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. AJR Am J Roentgenol 160 (1993) 533-538
42. Yamashita Y., Mizutani H., Torashima M., et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR Am J Roentgenol 161 (1993) 595-599
43. Kinkel K., Kaji Y., Yu K.K., et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212 (1999) 711-718
44. Belhocine T., De Barsy C., Hustinx R., et al. Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29 (2002) 1132-1139
45. Saga T., Higashi T., Ishimori T., et al. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 17 (2003) 197-203
46. Pecorelli S., and Odicino F. Cervical cancer staging. Cancer J 9 (2003) 390-394
47. Vidaurreta J., Bermudez A., di Paola G., et al. Laparoscopic staging in locally advanced cervical carcinoma: a new possible philosophy?. Gynecol Oncol 75 (1999) 366-371
48. Lagasse L.D., Creasman W.T., Shingleton H.M., et al. Results and complications of operative staging in cervical cancer: experience of the Gynecology Oncology Group. Gynecol Oncol 9 (1980) 90-98
49. LaPolla J.P., Schlaerth J.B., Gaddis O., et al. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 24 (1986) 194-199
50. Van Nagell Jr. J.R., Roddick Jr. J.W., and Lowin D.M. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findings. Am J Obstet Gynecol 110 (1971) 973-978
51. Hricak H., Lacey C.G., Sandles L.G., et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166 (1998) 623-631
52. Russell A.H., Anderson M., Walter J., et al. The integration of computed tomography and magnetic resonance imaging in treatment planning for gynecologic cancer. Clin Obstet Gynecol 35 (1992) 55-72
53. Subak L.L., Hricak H., Powell C.B., et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86 (1995) 43-50
54. Kim S.H., Choi B.I., Lee H.P., et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 175 (1990) 45-51
55. Kamura T., Tsukamoto N., Tsuruchi N., et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 69 (1992) 181-186
56. Innocenti P., Pulli F., Savino L., et al. Staging of cervical cancer: reliability of transrectal US. Radiology 185 (1992) 201-205
57. Aoki S., Hata T., Senoh D., et al. Parametrial invasion of uterine cervical cancer assessed by transrectal ultrasound: preliminary report. Gynecol Oncol 36 (1990) 82-89
58. Kim S.H., Choi B.I., Kim J.K., et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 17 (1993) 633-640
59. Pannu H.K., Corl F.M., and Fishman E.K. CT evaluation of cervical cancer: spectrum of disease. Radiographics 21 (2001) 1155-1168
60. Janus C.L., Mendelson D.S., Moore S., et al. Staging of cervical carcinoma: accuracy of magnetic resonance imaging and computed tomography. Clin Imaging 13 (1989) 114-116
61. Walsh J.W., and Goplerud D.R. Prospective comparison between clinical and CT staging in primary cervical carcinoma. AJR Am J Roentgenol 137 (1981) 997-1003
62. Yang W.T., Lam W.W., Yu M.Y., et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 175 (2000) 759-766
63. Scheidler J.J., Hricak H., Yu K.K., et al. Radiological evaluation of lymph node metastases in patients with cervical cancer: a meta-analysis. JAMA 278 (1997) 1096-1101
64. Hawnaur J.M., Johnson R.J., Buckley C.H., et al. Staging, volume estimation, and assessment of nodal status in carcinoma of the cervix: comparison of magnetic imaging with surgical findings. Clin Radiol 49 (1994) 443-452
65. Sironi S., De Cobelli F., Scarfone G., et al. Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness. Radiology 188 (1993) 797-801
66. Sheu M., Chang C., Wang J., et al. MR staging of clinical stage I and IIa cervical carcinoma: a reappraisal of efficacy and pitfalls. Eur J Radiol 38 (2001) 225-231
67. Hawighorst H., Knapstein P.G., Weikel W., et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 201 (1996) 531-539
68. Kim S.H., and Han M.C. Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol 168 (1997) 393-397
69. Umesaki N., Tanaka T., Miyama M., et al. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer. Oncol Rep 7 (2000) 1261-1264
70. Sugawara Y., Eisbruch A., Kosuda S., et al. Evaluation of FDG PET in patients with cervical cancer. J Nuc Med 40 (1999) 1125-1131
71. Sironi S., Buda A., Picchio M., et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238 (2006) 272-279
72. Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218 (2001) 776-782
73. Rose P.G., Adler L.P., Rodriguez M., et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17 (1999) 41-45
74. Havrilesky L.J., Kulasingam S.L., Matchar D.B., et al. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97 (2005) 183-191
75. Ozsarlak O., Tjalma W., Schepens E., et al. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur Radiol 13 (2003) 2338-2345
76. Amendola M.A., Hricak H., Mitchell D.G., et al. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. J Clin Oncol 23 (2005) 7454-7459
77. Bipat S., Glas A.S., van der Velden J., et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91 (2003) 59-66
78. Hricak H., Gatsonis C., Chi D.S., et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23 (2005) 9329-9337
79. Burke T.W., Hoskins W.J., Heller P.B., et al. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol 69 (1987) 382-385
80. Kaur H., Silverman P.M., Iyer R.B., et al. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180 (2003) 1621-1631
81. Hawighorst H., Knapstein P.G., Schaeffer U., et al. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. AJR Am J Roentgenol 166 (1996) 401-408
82. Kinkel K., Ariche M., Tardivon A.A., et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 204 (1997) 55-63
83. Yamashita Y., Harada M., Torashima M., et al. Dynamic MR imaging of recurrent postoperative cervical cancer. J Magn Reson Imaging 6 (1996) 167-171
84. Ryu S.Y., Kim M.H., Choi S.C., et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 44 (2003) 347-352
85. Havrilesky L.J., Wong T.Z., Secord A.A., et al. The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 90 (2003) 186-190
86. Unger J.B., Ivy J.J., Connor P., et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol 94 (2004) 212-216
87. Chang T.C., Law K.S., Hong J.H., et al. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study. Cancer 101 (2004) 164-171